CAR-based cellular therapy for refractory systemic lupus erythematosus: an overlap-controlled systematic review - Quiz - MDSpire

CAR-based cellular therapy for refractory systemic lupus erythematosus: an overlap-controlled systematic review

  • By

  • Sheng-Guang Li

  • Ruohan Yu

  • Lina Zhang

  • Jing Zhang

  • Yadan Zou

  • Ji Li

  • Ting Long

  • Yanfeng Zhang

  • Jing Pan

  • July 1, 2026

  • 0 min

Share

Original Source(s)

CAR-based cellular therapy for refractory systemic lupus erythematosus: an overlap-controlled systematic review

  • by Sheng-Guang Li, Ruohan Yu, Lina Zhang, Jing Zhang, Yadan Zou, Ji Li, Ting Long, Yanfeng Zhang, Jing Pan

  • July 1, 2026

Related Content

Accelerated immunosenescence in SLE: current evidence and clinical translation

Expression characteristics of C-reactive protein in autoimmune diseases and their complications

Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis